SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-287262
Filing Date
2019-11-07
Accepted
2019-11-07 16:02:54
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d667344d10q.htm 10-Q 338869
2 EX-31.1 d667344dex311.htm EX-31.1 10732
3 EX-31.2 d667344dex312.htm EX-31.2 10717
4 EX-32.1 d667344dex321.htm EX-32.1 5428
11 GRAPHIC g667344g59z57.jpg GRAPHIC 100671
  Complete submission text file 0001193125-19-287262.txt   3232582

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20190930.xml EX-101.INS 555103
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20190930.xsd EX-101.SCH 34490
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20190930_cal.xml EX-101.CAL 24818
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20190930_def.xml EX-101.DEF 259381
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20190930_lab.xml EX-101.LAB 308246
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20190930_pre.xml EX-101.PRE 285490
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 191200205
SIC: 2834 Pharmaceutical Preparations